dc.creator | Bustamante, D. | |
dc.creator | Morales, M. | |
dc.creator | Pelissier Serrano, Teresa | |
dc.creator | Saavedra, H. | |
dc.creator | Miranda, H. | |
dc.creator | Paeile, C. | |
dc.date.accessioned | 2018-12-20T15:05:11Z | |
dc.date.available | 2018-12-20T15:05:11Z | |
dc.date.created | 2018-12-20T15:05:11Z | |
dc.date.issued | 1989 | |
dc.identifier | General Pharmacology, Volumen 20, Issue 5, 1989, Pages 605-608 | |
dc.identifier | 03063623 | |
dc.identifier | 10.1016/0306-3623(89)90094-3 | |
dc.identifier | http://repositorio.uchile.cl/handle/2250/157705 | |
dc.description.abstract | 1. The cardiovascular effects of CLX were studied. 2. CLX induced hypotension, bradycardia, negative chronotropism and negative inotropism. 3. Electrophysiological studies showed a decrease of sinus venosus discharge frequency. The action potential configuration was changed: the overshoot amplitude and (dV/dt)max were reduced and duration increased. 4. CLX at higher concentrations displaced the maximum diastolic potential and phase 4 slow diastolic depolarization was lengthened. 5. The above findings could be explained by a depressant action of CLX on the electrical activity of the pacemaker cells, possibly by a modification of the slow calcium currents. | |
dc.language | en | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
dc.source | General Pharmacology | |
dc.subject | Pharmacology | |
dc.title | Experimental cardio-depressant effects of clonixin | |
dc.type | Artículos de revistas | |